Abstract

BackgroundOesophageal adenocarcinoma (EAC) incidence is increasing and has a poor survival rate. Barrett’s oesophagus (BE) is a precursor condition that is associated with EAC and often occurs in conjunction with chronic gastro-oesophageal reflux, however many individuals diagnosed with BE never progress to cancer. An understanding of the genomic features of BE and EAC may help with the early identification of at-risk individuals.MethodsIn this study, we assessed the genomic features of 16 BE samples using whole-genome sequencing. These included non-dysplastic samples collected at two time-points from two BE patients who had not progressed to EAC over several years. Seven other non-dysplastic samples and five dysplastic BE samples with high-grade dysplasia were also examined. We compared the genome profiles of these 16 BE samples with 22 EAC samples.ResultsWe observed that samples from the two non-progressor individuals had low numbers of somatic single nucleotide variants, indels and structural variation events compared to dysplastic and the remaining non-dysplastic BE. EAC had the highest level of somatic genomic variations. Mutational signature 17, which is common in EAC, was also present in non-dysplastic and dysplastic BE, but was not present in the non-progressors. Many dysplastic samples had mutations in genes previously reported in EAC, whereas only mutations in CDKN2A or in the fragile site genes appeared common in non-dysplastic samples. Rearrangement signatures were used to identify a signature associated with localised complex events such as chromothripsis and breakage fusion-bridge that are characteristic of EACs. Two dysplastic BE samples had a high contribution of this signature and contained evidence of localised rearrangements. Two other dysplastic samples also had regions of localised structural rearrangements. There was no evidence for complex events in non-dysplastic samples.ConclusionsThe presence of complex localised rearrangements in dysplastic samples indicates a need for further investigations into the role such events play in the progression from BE to EAC.

Highlights

  • Oesophageal adenocarcinoma (EAC) incidence is increasing and has a poor survival rate

  • Barrett’s oesophagus (BE) has been proposed to involve progression through a number of histologic stages starting with a non-dysplastic metaplastic stage, through low-grade dysplasia (LGD), high-grade dysplasia (HGD) before leading to the development of EAC [5]

  • In order to be conservative in the analysis we only considered high level amplifications, homozygous deletions or regions with significant gain or loss in a duplicated genome, in a similar manner to that described in the COSMIC database

Read more

Summary

Introduction

Oesophageal adenocarcinoma (EAC) incidence is increasing and has a poor survival rate. Barrett’s oesophagus (BE) is a precursor condition that is associated with EAC and often occurs in conjunction with chronic gastro-oesophageal reflux, many individuals diagnosed with BE never progress to cancer. The incidence of oesophageal adenocarcinoma (EAC) is increasing in Western countries and the long-term survival rate for the cancer is poor, with a 5-year survival rate of 14% [1, 2]. The strongest risk factor for developing EAC is being diagnosed with the precursor condition, Barrett’s oesophagus (BE) [3]. The majority of patients diagnosed with BE do not go on to develop EAC and are termed non-progressors [6]. The molecular basis for the progression of BE to EAC in those individuals who develop cancer, termed progressors, is not yet fully understood

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call